An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis

Indian Journal of Dermatology, Venereology and Leprology

Volumn 73, Issue 6, 2007, Pages 393-396

  Jaiswal, Amit ^a   Sharma, R ^a   Garg, A ^b  

^a LLRM MEDICAL COLLEGE   (India)

^b CH CHARAN SINGH UNIVERSITY   (India)

Author keywords

Dermatophytes; Mold; Onychomycosis; Pulse therapy; Yeasts

Indexed keywords

AM LAQER; AMOROLFINE; CICLOPIROXOLAMINE; ONYLAC; TERBINAFINE; UNCLASSIFIED DRUG; ZIMIG;

ARTICLE; ASPERGILLUS; CANDIDA ALBICANS; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATOPHYTE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; ONCHOCERCIASIS; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT RESPONSE; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS;

EID: 36448974563     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.37056     Document Type: Article

References (14)

1. Gupta AK, Lynde CW, Konnikov N. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis. J Am Acad Dermatol 2001;44:485-91.
2. Tosti A, Piraccini BM, Stinchi C, Venturo N, Bardazzi F, Colombo MD. Treatment of dermatophyte nail infections: An open randomized study comparing intermittent terbinafine therapy with continuous terbinafine treatment and intermittent itraconazole therapy. J Am Acad Dermatol 1996;34:595-600.
3. Nolting S, Brautigam M, Weidinger G. Terbinafine in onychomycosis with involvement by non-dermatophytic fungi. Br J Dermatol 1994;130:16-21.
4. Mishra M, Panda P, Tripathy S, Sengupta S, Mishra K. An open randomized comparative study of oral itraconazole pulse and terbinafine pulse in the treatment of onychomycosis. Indian J Dermatol Venereol Leprol 2005;71:262-6.
5. Gupta AK, Flerkman P, Barean R. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis. J Am Acad Dermatol 2000;43:70-80.
6. Ulbricht H, Worz K. Therapy of onychomycosis due to molds with ciclopirox nail lacquer. Mycoses 1994;37:97-100.
7. Zaug M. Amorolfine nail lacquer: Once-weekly application in onychomycosis. JAMA South East Asia 1993;9:19-22.
8. Gupta AK, Scher RK, De Doncker P. Current management of onychomycosis: An overview. Dermatol Clin 1997;15:121-35.
9. Scher RK. Diseases of the nails. In: Conn H, editor. Current therapy. Philadelphia: WB Saunders Co; 1990. p. 736-42.
10. Polak AM. Preclinical data and mode of action of amorolfine. Clin Exp Dermatol 1992;17:8-12.
11. Franz TJ. Absorption of amorolfine through human nail. Dermatology 1982;184:18-20.
12. Pavlotsky F, Armoni G, Shemer A, Trau H. Pulsed versus continuous terbinafine dosing in the treatment of dermatophyte onychomycosis. J Dermatolog Treat 2004;15:315-20.
13. Avner S, Nir N, Henri T. Pulsed versus continuous terbinafine dosing in the treatment of dermatophyte onychomycosis. J Dermatolog Treat 2005;16:327-30.
14. Baran R, Sigurgeirsson B, Berker D, Kaufmann R, Lecha M, Faergemann J, et al. A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement. Br J Dermatol 2007;157:149-57.